Study reveals low rates of targeted drug use among older black women with early-stage

[News]

The advent of targeted drugs for a specific type of breast cancer - HER2 positive - has dramatically improved survival rates for women with the disease. But a study led by researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center reveals low rates of use of a targeted drug among older women with early-stage breast cancer of this type, and even lower rates for older black women.

More... (http://www.news-medical.net/news/20160413/Study-reveals-low-rates-of-targeted-drug-use-among-older-black-women-with-early-stage-breast-cancer.aspx)